DDI-related ADRs | pDDIs pairs | Lexi-Interact | Micromedex | Number of actual DDI | Actual DDI DIPS score | Time to develop ADRs after drug combination, (days) | Management |
---|---|---|---|---|---|---|---|
Hypoglycemia | Linezolid-Insulin | C-Moderate | Moderate | 5 | 3, 3, 4, 4, 4 | 6.2 ± 0.75 | Adjust insulin/hypoglycemic agent dose, and monitor blood glucose |
Levofloxacin-Hypoglycemic agent | C-Moderate | Major | 4 | 3, 3, 5, 5 | 4.25 ± 0.83 | ||
Nephrotoxicity | Cefoperazone-Furosemide | C-Moderate | Major | 4 | 4, 5, 5, 6 | 6 ± 1.58 | Adjust dose of cephalosporins, monitor renal function |
Vancomycin-Loop Diuretics | C-Moderate | None | 3 | 5, 6, 7 | 3.67 ± 0.47 | Discontinue vancomycin or Change it to linezolid | |
Vancomycin-Piperacillin/Tazobactam | C-Moderate | Major | 3 | 4, 6, 7 | 5.67 ± 2.05 | ||
Levofloxacin-NSAIDs* | C-Major | Moderate | 1 | 6 | 6 | Change quinolones to other antibiotics | |
Amikacin-Vancomycin | D-Moderate | Major | 1 | 8 | 4 | Change vancomycin or amikacin to other antibiotics | |
Amikacin-Torsemide | C-Moderate | Moderate | 1 | 6 | 5 | ||
Amikacin-Furosemide | C-Moderate | Moderate | 2 | 7, 7 | 5.5 ± 0.5 | ||
Hypertension | Linezolid-Dopamine | D-Major | Contraindicated | 2 | 5, 5 | 7.5 ± 0.5 | Add antihypertensive drugs and monitor blood pressure |
Linezolid-Noradrenaline | D-Moderate | Major | 2 | 5, 5 | 4.5 ± 0.5 | ||
Linezolid-Aminophylline | D-Moderate | none | 2 | 2, 3 | 6.5 ± 0.5 | ||
Linezolid-Metoclopramide | X-Moderate | None | 1 | 2 | 6 | ||
Linezolid-Epinephrine | None | Contraindicated | 2 | 3, 4 | 4.5 ± 0.5 | ||
QT prolongation | Linezolid-Ondansetron | C-Moderate | Major | 3 | 3, 4, 4 | 5.33 ± 1.25 | Monitor clinical symptoms and change or discontinue related medications as needed |
Levofloxacin-Ondansetron | C-Moderate | Major | 3 | 3, 4, 4 | 4.33 ± 1.25 | ||
Fluconazole-Amiodarone | D-Major | Contraindicated | 2 | 6, 6 | 7 ± 1 | ||
Fluconazole-Ondansetron | None | Contraindicated | 2 | 3, 4 | 7 ± 2 | ||
Levofloxacin-Famotidine | None | Major | 2 | 5, 6 | 8.5 ± 1.5 | ||
Levofloxacin-Amiodarone | X-Major | None | 1 | 7 | 4 | ||
Voriconazole-Propofol | C-Moderate | None | 1 | 6 | 7 | ||
Metronidazole-Famotidine | None | Major | 1 | 4 | 6 | ||
Bleeding | Cefoperazone-Heparin | None | Major | 4 | 3, 3, 3, 4 | 4 ± 1.22 | Adjust the dose of anticoagulant drugs to monitor coagulation function and bleeding |
Fluconazole-Rivaroxaban | C-Major | Moderate | 1 | 5 | 11 | ||
Cardiac arrhythmias | Metronidazole-Dexmedetomidine | None | Major | 1 | 5 | 9 | Discontinue metronidazole |
Angina | Fluconazole-Clopidogrel | D-Major | Major | 1 | 3 | 6 | Change fluconazole to voriconazole |
Nausea, vomiting | Ciprofloxacin-Aminophylline | D-Major | None | 3 | 5, 6, 6 | 5.67 ± 1.25 | Add antiemetics |
Imipenem-Theophylline | None | Major | 1 | 4 | 3 | Â | |
Seizures | Voriconazole-Tramadol | C-Moderate | Major | 1 | 3 | 5 | Change tramadol to flurbiprofen |
Serotonin syndrome | Linezolid-Morphine | X-Moderate | None | 1 | 6 | 4 | Change linezolid to vancomycin |
Respiratory depression | Voriconazole-Sufentanil | C-Moderate | Major | 1 | 3 | 3 | Discontinue sufentanil |